These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9565633)

  • 21. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
    Schulz R; Mellor AL
    J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
    Bikoff EK
    J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High efficiency of endogenous antigen presentation by MHC class II molecules.
    Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class II MHC self-antigen presentation in human B and T lymphocytes.
    Costantino CM; Spooner E; Ploegh HL; Hafler DA
    PLoS One; 2012; 7(1):e29805. PubMed ID: 22299025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands.
    Wong P; Barton GM; Forbush KA; Rudensky AY
    J Exp Med; 2001 May; 193(10):1179-87. PubMed ID: 11369789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
    Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
    J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
    Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
    Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.
    Muixí L; Contreras V; Collado JA; Alexandre Y; Ballingall K; Bonneau M; Jaraquemada D; Schwartz-Cornil I
    Int Immunol; 2012 Jan; 24(1):59-69. PubMed ID: 22194283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: role of T-cell activation state and costimulatory signals.
    Celis E; Goodwin JJ; Saibara T
    Hum Immunol; 1992 Jul; 34(3):173-80. PubMed ID: 1429042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of antigen processing on thymic T-cell selection.
    Hadzija M; Semple JW; Delovitch TL
    Res Immunol; 1991; 142(5-6):421-4. PubMed ID: 1754714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
    Vignali DA; Urban RG; Chicz RM; Strominger JL
    Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells.
    Burkly LC; Lo D; Flavell RA
    Science; 1990 Jun; 248(4961):1364-8. PubMed ID: 1694042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.